top of page

We help turn groundbreaking scientific discoveries into successful startups and spin-offs. 
By connecting innovation with capital and expertise, we create growth opportunities. Our objective is to identify new inventions in Drug Discovery, Diagnostics, MedTech and other Life Science fields. This is an overview of our current portfolio:

Portofolio companies

portfolio loga s pozadím pro web2.jpg
Adalid Science
Novel lipid nanoparticles for effective drug delivery
Czech Republic
portfolio loga s pozadím pro web8.jpg
Dracen Pharmaceuticals
Tumor-Directed Glutamine Antagonist
Czech Republic/ USA
portfolio loga s pozadím pro web13.jpg
PerioTrap
Curative treatment of periodontitis
Germany
portfolio loga s pozadím pro web18.jpg
Sophpomer
Syntetic polymer for immunoassays
Czech Republic
portfolio loga s pozadím pro web4.jpg
CasInvent Pharma
Casein Kinase 1 inhibitors for cancer treatment
Czech Republic
portfolio loga s pozadím pro web9.jpg
LAM-X
Light-activated nanomaterials fighting infections
Czech Republic
portfolio loga s pozadím pro web14.jpg
Reecyclium
Separation of rare elements from permanent magnets
Czech Republic
portfolio loga s pozadím pro web20.jpg
Sulfotools
Green peptide synthesis technology
Germany
portfolio loga s pozadím pro web6.jpg
Deep MedChem
AI-based tools accelerating drug discovery
Czech Republic
portfolio loga s pozadím pro web11.jpg
Pep-Therapy
Innovative peptides for oncology
France
portfolio loga s pozadím pro web16.jpg
Sampling Human
Yeast cell based biocomputing
Czech Republic/USA

Projects in incubation

Here you will find a list of projects that are currently included in our incubation programme:

projects.jpg
Promental Health
In vitro diagnostic panel of novel microRNA
biomarkers for early diagnosis of Alzheimer’s disease.

Poland
projects2.jpg
Insert
A system for liquid-liquid microseparations,
enabling sample preparation for GC and HPLC analysis.

Czech Republic
projects3.jpg
Funbrush
Covalent fluorescent probe designed for tagged proteins for biomolecular interaction studies.
Czech Republic

Our exits

Our role is to help launch new startups or spin-offs. The moment our role ends, the exit follows. Here is an overview of our exits: 

exit.jpg
Diana Biotechnologies
Pharmaceuticals and highly sensitive diagnostics
Czech Republic
exit2.jpg
Elphogene
Liquid biopsy technology for cancer diagnostics
Czech Republic
exit3.jpg
Riocath
New technology used in the production of catheters
Czech Republic
i&i_logo_dovetek_horizont_WHITE.png
Pobřežní 394/12,
186 00 Prague, Czech Republic

+420 725 152 013

  • LinkedIn

©2022 od Martin Kovalčík. Vytvořeno pomocí Wix.com

bottom of page